2018 (v1)
Publication
No description
Uploaded on: April 14, 2023
-
-
2020 (v1)Publication
There is limited data regarding the impact of body mass index (BMI) on outcomes in advanced breast cancer (BC), especially in patients treated with endocrine therapy (ET) + CDK 4/6 inhibitors.
Uploaded on: April 14, 2023 -
2018 (v1)Publication
Safety of pregnancy in women with history of estrogen receptor (ER)–positive breast cancer remains controversial. In this multicenter case–control study, 333 patients with pregnancy after breast cancer were matched (1:3) to 874 nonpregnant patients of similar characteristics, adjusting for guaranteed time bias. Survival estimates were...
Uploaded on: March 27, 2023 -
2022 (v1)Publication
The prognostic performance of PREDICT in patients with HER2-positive early breast cancer (EBC) treated in the modern era with effective chemotherapy and anti-HER2 targeted therapies is unclear. Therefore, we investigated its prognostic performance using data extracted from ALTTO, a phase III trial evaluating adjuvant lapatinib +/- trastuzumab...
Uploaded on: January 31, 2024 -
2020 (v1)Publication
No description
Uploaded on: April 14, 2023